Immunicom Inc
Immunicom Inc., based in San Diego, CA, is a pioneering biotechnology company focused on creating innovative immunotherapies designed to enhance patient quality of life while addressing various diseases, including cancer. Their flagship treatment, Immunopheresis, employs a breakthrough technology platform that aims to remove barriers from the blood that hinder the immune system, offering a novel approach to managing numerous health conditions.
The company is recognized for its commitment to advancing cancer treatment, having received European CE Mark Certification for its LW-02 immunotherapy device specifically targeting advanced refractory triple-negative breast cancer. Currently, Immunicom is engaged in worldwide clinical trials evaluating the effectiveness of Immunopheresis across multiple cancer types, both as a standalone therapy and in conjunction with existing treatments.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.